2.69 USD
↗ 0.01 (0.45%)LIVE (AS OF 12:06 PM EDT)
AC Immune SA (ACIU) trades at $2.69 per share. Technical indicators currently signal "Neutral". This is driven by a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$2.68
High?$2.73
Low?$2.64
Prev. Close?$2.68
Volume?53.8K
Avg. Volume?N/A
VWAP?$2.68
Bid / Ask
Bid?$2.68 × 200
Ask?$2.70 × 200
Spread?$0.02
Midpoint?$2.69
Valuation & Ratios
Market Cap?266.5M
Shares Out?101.8M
Float?74.7M
Float %?73.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Themes
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?4.41%Low
Short Interest?3.3M
Days to Cover?15.0
Free Float74.7M
Avg Daily Volume219.9K
Settlement Date2026-08-31